SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-10-015735
Filing Date
2010-03-26
Accepted
2010-03-26 06:05:30
Documents
4
Period of Report
2010-03-26

Document Format Files

Seq Description Document Type Size
1 v178701_6k.htm 6-K 5120293
2 GRAPHIC chart.jpg GRAPHIC 48749
3 GRAPHIC logo.jpg GRAPHIC 8981
4 GRAPHIC logo1.jpg GRAPHIC 15968
  Complete submission text file 0001144204-10-015735.txt   5223655
Mailing Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989
Business Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989 972-8-930-4440
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 000-51310 | Film No.: 10706078
SIC: 2834 Pharmaceutical Preparations